Skip to main content
OpenTrials
Completed

NCT Number: NCT04996901

The Chinese STEMI PPCI Registry (CSPR)

The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ST-segment Elevation Myocardial Infarction (STEMI) Cardiovascular Diseases Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms ST Elevation Myocardial Infarction Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Renmin Hospital of Wuhan university

Wuhan, Hubei, 430000, China

About this study

The CSPR trial is an observational clinical trial to derive and validate a readily useable risk score to identify patients at high risk of in-hospital major adverse cardiac events in 5594 patients presenting with a ST-segment elevation myocardial infarction and treated by primary percutaneous coronary intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age≥18
  • ST-segment elevation myocardial infarction was defined according to the universal definition of myocardial infarction
  • STEMI treated by pPCI

Exclusion criteria

  • Patient with heart failure in admission
  • STEMI with symptom-onset-to-balloon time>24h
  • pPCI was not successful or only underwent coronary angiography
  • Killip class ≥II in admission

Treatment and study plan

No intervention

Other

no intervention

Primary outcomes

  1. in-hospital acute de novo heart failure

    Time frame: in-hospital outcome, until discharge

    Killip class ≥II

  2. cardiogenic shock

    Time frame: in-hospital outcome, until discharge

    according to the universal definition

  3. death

    Time frame: in-hospital outcome, until discharge

    according to the universal definition

Sponsors and collaborators

Lead sponsor

Renmin Hospital of Wuhan University

Other

Collaborators

  • Jiangxi Provincial People's Hopital
  • The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture
  • The First Affiliated Hospital of Dalian Medical University
  • The First College of Clinical Medical Science, China Three Gorges University
  • Wuhan Third Hospital
  • Xiangyang No.1 People's Hospital

Registry information

Official study title

The Chinese ST-Segment Elevation Myocardial Infarction Primary Percutaneous Coronary Intervention Registry

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Aug 9, 2021
Registry last updated
Dec 20, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.